CRVS 241115 6.00P (CRVS241115P6000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CRVS241115P6000

Watchlist

0.10
0.000.00%

15min DelayTrading Nov 8 12:16 ET

0.21High0.10Low

Intraday

5D
Daily

News

Earnings Preview: CRVS to Report Financial Results Post-market on November 12
Moomoo NewsNov 6 20:00 ET
Express News | Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2024 Financial Results on November 12, 2024
ReutersNov 5 16:02 ET
Corvus Pharmaceuticals Options Imply 12.0% Move in Share Price Post-earnings
TipRanksNov 5 15:20 ET
Corvus Stock Climbs 7% Following Mizuho Upgrade
Seeking AlphaOct 22 11:49 ET · Ratings
Mizuho Securities Upgrades Corvus Pharmaceuticals(CRVS.US) to Buy Rating, Announces Target Price $12
Moomoo NewsOct 22 06:37 ET · Ratings
Express News | Corvus Pharmaceuticals Inc : Mizuho Raises Target Price to $12 From $3.5
ReutersOct 22 05:35 ET

Comments

71179109

Nov 6 10:55

$Corvus Pharmaceuticals (CRVS.US)$vibrating so much every day… what’s the reasonable price???

Bigmoney Dreamer

Oct 30 15:35

$Corvus Pharmaceuticals (CRVS.US)$

Bigmoney Dreamer

Oct 30 15:35

$Corvus Pharmaceuticals (CRVS.US)$

Bigmoney Dreamer

Oct 29 15:47

$Corvus Pharmaceuticals (CRVS.US)$ 👀 📖
Corvus Pharmaceuticals Inc. carries a moderately high risk level, given its mixed fundamentals and recent volatility. Although positive analyst sentiment and a key drug catalyst suggest potential upward movement, the company's financials signal instability with negative earnings and high cash burn. The stock’s position below its 52-week high with an ongoing sector underperformance adds to the unpredictability. Moreover, the biotechnology sector can present ...

Jsmooth420365

Oct 29 12:13

$SKK Holdings (SKK.US)$ $Corvus Pharmaceuticals (CRVS.US)$ are my main 2 as of now